Status:
COMPLETED
Calcium-protein Co-ingestion and Gut Hormones
Lead Sponsor:
University of Bath
Conditions:
Obesity
Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Gut hormones have therapeutic potential in the prevention and treatment obesity and type 2 diabetes (T2D). Rodent evidence suggests that calcium may potentiate the effects of protein ingestion on gut ...
Eligibility Criteria
Inclusion
- Healthy men and women age between 18-65 yrs.
- Able to consume provided supplement.
- Weight stable for the past 3 month (no change within 3%)
Exclusion
- Any previous or current metabolic, cardio-pulmonary or musculoskeletal disease
- Not between the ages of 18-65 years
- A body mass index below 18.5 kg/m2 or above 30 kg/m2 (body mass (kg) divided by your height (m) squared)
- Taking medications that may influence your metabolism
- Plans to change your lifestyle (diet and/or physical activity) during the study period
- Not willing to refrain from alcohol containing drinks or unaccustomed exercise one day before the laboratory sessions.
- Current smoker
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03370497
Start Date
October 1 2017
End Date
February 28 2018
Last Update
August 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department for Health, University of Bath
Bath, United Kingdom, BA2 7AY